4502 — Takeda Pharmaceutical Co Cashflow Statement
0.000.00%
Last trade - 00:00Annual cashflow statement for Takeda Pharmaceutical Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Yuho | Yuho | Yuho | Yuho | Tanshin |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 230,166 | 317,038 | 144,197 | 108,143 | 192,026 |
| Depreciation | |||||
| Non-Cash Items | 252,109 | 327,626 | 182,842 | 452,700 | 564,338 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 57,679 | -331,908 | -338,697 | -265,057 | -436,060 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 1,123,105 | 977,156 | 716,344 | 1,057,182 | 1,041,431 |
| Capital Expenditures | -186,037 | -633,689 | -480,730 | -347,841 | -410,933 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -12,088 | 26,587 | 16,868 | -19,219 | 41,792 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -198,125 | -607,102 | -463,862 | -367,060 | -369,141 |
| Financing Cash Flow Items | -108,592 | -117,732 | -126,478 | -129,633 | -134,392 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -1,070,265 | -709,148 | -354,416 | -751,425 | -496,820 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -116,527 | -316,165 | -75,730 | -72,688 | 209,942 |